IPP Bureau
Medtech player Healthium acquires CareNow
By IPP Bureau - September 02, 2021
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
Medtronic partners with Stasis to enhance patient monitoring in India
By IPP Bureau - September 02, 2021
The Stasis connected care monitoring system includes - a bedside monitor that monitors 6 vital signs, a tablet that enables intuitive monitoring, and the Stasis app that allows for remote monitoring across devices
Janssen announces U.S. FDA approval of Invega Hafyera
By IPP Bureau - September 02, 2021
Invega Hafyera offers patients the fewest doses per year. Phase 3 non-inferiority study results showed over 92% of participants were relapse-free at 12 months
Granules India receive DRDO licence to manufacture and market 2-DG
By IPP Bureau - September 02, 2021
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
Morpen Laboratories to transfer its medical devices business to a wholly owned subsidiary
By IPP Bureau - September 02, 2021
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
Union Minister Mansukh Mandaviya chairs meet on eradicating TB
By IPP Bureau - September 02, 2021
Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya
Shilpa Medicare receives approval for 2-Deoxy-2-Glucose powder
By IPP Bureau - September 01, 2021
The powder is approved for the treatment of adjunct therapy in moderate to severe Covid-19 patients
.jpg "Pharma tops India’s exports from SEZs")
Pharma tops India’s exports from SEZs
By IPP Bureau - September 01, 2021
As of June 30, 2021, 267 out of a total of 427 SEZs approved by the government are operational
.jpeg "Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1")
Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1
By IPP Bureau - September 01, 2021
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
WHO releases compendium of innovative health technologies
By IPP Bureau - September 01, 2021
The Covid-19 pandemic has exposed the divide that exists between rich and developing nations and to address these challenges the World Health Organisation (WHO), has compiled a list of innovative health technologies that aim to bridge the gap
Zymo Research receives CE Mark for new Covid-19 SafeCollect kits
By IPP Bureau - September 01, 2021
Self-collection devices designed for ease of use and safety
Positive results from Pfizer’s Phase 3 trail comparing efficacy of abrocitinib and dupilumab
By IPP Bureau - September 01, 2021
JADE DARE trial met co-primary and key secondary endpoints and demonstrated a safety profile consistent with previous studies for moderate to severe atopic dermatitis
SK Bioscience and GSK start Phase 3 trial of an adjuvanted COVID-19 vaccine candidate
By IPP Bureau - September 01, 2021
Advance to Phase 3 follows positive interim Phase 1/2 immunogenicity and safety data. The global clinical trial will evaluate vaccine candidate GBP510 against the AZ/Oxford COVID-19 vaccine
Metropolis Healthcare opens new testing centre in Thalassery, Kerala
By IPP Bureau - September 01, 2021
The lab will offer about 4,000 different tests ranging from basic to high-end molecular diagnostic tests
Two major hospitals in Gujarat announce tie-up
By IPP Bureau - September 01, 2021
Aashka Hospitals has entered into a non-binding agreement for its proposed tie-up with Vaidehi—Backbone hospital, Rajkot
